InvestorsHub Logo
Followers 29
Posts 2650
Boards Moderated 0
Alias Born 07/26/2016

Re: georgejjl post# 234991

Saturday, 07/21/2018 1:11:31 PM

Saturday, July 21, 2018 1:11:31 PM

Post# of 403058
George, Remicade (one of the first, if not the first immunologic), Humira and about 8 or 9 others have varying degrees of success and varying degrees of contraindications in the IBD-psoriasis-psoriatic arthritis-Crohn's continuum. And they all lose their effects over time, though not necessarily all their side effects. The difference is that they all have gone through an FDA 3 successfully. And IPIX has not. An oral compound with no/few debilitating side-effects that worked, even modestly, would be a hit. And if it did not cost $900 for less than 30 pills that would be a good thing for patients, insurers, hospital formularies,and even IPIX, though not necessarily for its competitors.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News